FDA Approves CAR T-cell Therapy for Pediatric Acute Lymphoblastic Leukemia (ALL)
FDA Approves CAR T-cell Therapy for Pediatric Acute Lymphoblastic Leukemia (ALL) The US Food and Drug Administration (FDA) has approved Kymriah (tisagenlecleucel) for certain children, adolescents, and youthfull adults with …Read more